Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of Transactions

R&M Logo

News provided by

Research and Markets

Apr 07, 2023, 12:00 ET

Share this article

Share toX

Share this article

Share toX

DUBLIN , April 7, 2023 /PRNewswire/ -- The "Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023" report has been added to  ResearchAndMarkets.com's offering.



The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2023 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.

This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic sectors. The report provides details of partnering deals disclosing royalty rates from 2010 to 2023.

The report provides an overview of how and why companies enter partnering deals where a royalty is payable upon commercialization of the compound or technology.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all partnering deals announced since 2010 where a quantitative royalty rate has been disclosed, as recorded in the Current Agreements deals and alliances database. Each deal record and royalty disclosure is available in further detail via a link to online copy of the deal including actual contract document, where available, as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of royalty rate trends in pharma and biotech since 2010. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in royalty rates in the pharma and biotech sectors since 2010, including a summary of the recent literature on the subject.

Chapter 3 provides a more detailed insight into the structure of a royalty rate clause and how it fits with the other financial terms of the partnering deal. The chapter includes numerous case studies for actual deals where royalty rates have been disclosed.

Chapter 4 provides an insight into companies active in disclosing royalty rates as well as those deals attracting the highest royalty rates, and why.

Chapter 5 provides comprehensive and detailed access to deals which disclose a royalty rate since 2010 where a contract document is available. Contract documents provide an in-depth insight into the actual deal terms agreed between the parties with respect to the royalty rate.

In addition the report includes a comprehensive appendix listing of all deals where a royalty rate has been disclosed announced since 2010. Each listing is organized as an appendix by company A-Z, stage of development at signing, therapeutic area, and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

The report also includes numerous table and figures that illustrate the trends in royalty rates in pharma and biotech deal making since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about royalty rates in the pharma and biotech sector.

Key benefits

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2023 provides the reader with the following key benefits:

  • In-depth understanding of royalty rate partnering deal trends since 2010
  • Analysis of the structure of royalty clauses with real life case studies
  • Comprehensive listing of all partnering deals since 2010 where a royalty rate is disclosed, together with deal terms, value and press release
  • Comprehensive access to actual partnering deal contracts entered into by the world's life science companies where a royalty rate is disclosed
  • Insight into the royalty terms included in a licensing agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2023 is intended to provide the reader with an in-depth understanding of the royalty rate trends and structure of deals entered into by leading life science companies worldwide.

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2023 includes:

  • Trends in royalty rates in the biopharma industry since 2010
  • Analysis of the structure of royalty clauses with real life case studies
  • Comprehensive listing of licensing deals which disclose royalty rates since 2010
  • Access to licensing contract documents which disclose royalty rates
  • The leading licensing deals by royalty rate value since 2010
  • Most active royalty rate disclosures since 2010

In Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2023 available deals and contracts are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.

The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023 report provides comprehensive access to available contract documents for licensing deals.

Analyzing actual contract agreements allows assessment of the following:

  • What are the precise royalty rates granted?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Companies Mentioned

  • 3D Medicines
  • Abbott Laboratories
  • Abbvie
  • Ablynx
  • Abraxis BioScience
  • Acceleron Pharma
  • Acerus
  • Actavis (acquired by Watson)
  • Active Biomaterials
  • Acura Pharmaceuticals
  • Adamis Pharmaceuticals
  • Adaptimmune
  • Adeona Pharmaceuticals
  • Adlai Nortye
  • Aduro BioTech
  • Advanced Dosage Forms
  • Advaxis
  • Advirna
  • Aegerion Pharmaceutical
  • AEterna Zentaris
  • Afritex Medical Products
  • Agenus Bio
  • Agios Pharmaceuticals
  • AIT Therapeutics
  • Akcea Therapeutics
  • Akebia Therapeutics
  • Alchemia
  • Alder Biopharmaceuticals
  • Alector
  • Alexion Pharmaceuticals
  • Alexza Pharmaceuticals
  • Alfasigma
  • Alfa Wassermann
  • Allergan
  • Allergan (name changed from Actavis)
  • Almirall
  • Alnylam Pharmaceuticals
  • Alternavida
  • Altman Enterprises
  • AltrazealTrading
  • Amarantus BioSciences
  • American Type Culture Collection (ATCC)
  • Amgen
  • Amherst Pharmaceuticals
  • Amorfix Life Sciences
  • Ampio Pharmaceuticals
  • Amylin Pharmaceuticals
  • Amyris
  • AnaBios
  • AnGes MG
  • AnnaMed
  • Antibe Therapeutics
  • Antigen Express
  • Apricus Biosciences
  • Aquestive Therapeutics
  • Aradigm
  • Aratana Therapeutics
  • Arch Pharmalabs
  • Ardelyx
  • Arena Pharmaceuticals
  • Assembly Biosciences
  • Astellas Pharma
  • Astellas Pharma Europe
  • Asterias Biotherapeutics
  • AstraZeneca
  • Athenex
  • Atossa Genetics
  • Audeo Oncology
  • Aurigene Discovery Technologies
  • Authentic Brands Group
  • AVEO Oncology
  • Avita Medical
  • Avivagen
  • Axovant Sciences
  • Aytu BioScience
  • Azaya Therapeutics
  • Azure Biotech
  • Baker Brothers Investments
  • BASF
  • Baxter International
  • Bayer Healthcare
  • Bayer Innovation
  • Baylor Research Institute
  • Belgian Volition
  • Bellerophon Therapeutics
  • Benitec Biopharma
  • Besins Healthcare
  • Beth Israel Deaconess Medical Center
  • BIND Biosciences
  • BioCorRx
  • BioCryst Pharmaceuticals
  • Bioeq IP
  • Biogen
  • BioGene Technology
  • BioInvent
  • BiolineRX
  • BioMarin Pharmaceutical
  • BioNovion
  • BioNTech
  • Biopharmex
  • BiopharmX
  • BioPorto
  • Bioprocess Capital Ventures
  • BioProspect
  • Biostem US
  • Biotech Investment
  • Biotechnology Value Fund
  • BioTime Acquisition
  • Bioton
  • Biovail
  • BioZone Laboratories
  • BioZone Pharmaceuticals
  • Bluebird Bio
  • BMV Medica
  • Boehringer Ingelheim
  • Braeburn Pharmaceuticals
  • BrainStorm Cell Therapeutics
  • Breathtec BioMedical
  • Bristol-Myers Squibb
  • Caleco Pharma
  • Calico
  • Can-Fite BioPharma
  • Cancer Prevention Pharmaceuticals
  • CanniMed Therapeutics
  • Canntab Therapeutics
  • Cannus Partners
  • Cantex Pharmaceuticals
  • Cardigant Medical
  • Cardium Therapeutics
  • CareFusion
  • Cary Pharmaceuticals
  • Castle Creek Pharmaceuticals
  • Catalent
  • CB2 Therapeutics
  • Celdara Medical
  • Celgene
  • Cell Cure Neurosciences
  • Cel Sci
  • Celyad
  • Cereal Ingredients
  • Cerus
  • cGreen
  • Chi-Med
  • Chiesi Farmaceutici
  • Chimerix
  • Chong Kun Dang
  • Chongqing Jingdong Pharmaceutical
  • Cimtech
  • Cipher Pharmaceuticals
  • Cipla
  • Circassia
  • Clal Biotech
  • Clalit Health Services
  • Clemson University
  • Cleveland BioLabs
  • Clinigen
  • CMIC
  • CNS Pharmaceuticals
  • Cocrystal Pharma
  • Coeptis Pharmaceuticals
  • Cohen-McNiece Foundation
  • Coherus Biosciences
  • Colby Pharmaceuticals
  • Columbia Laboratories
  • Columbia University
  • Common Sense
  • Concile
  • ContraFect
  • Coronado Biosciences
  • CRISPR Therapeutics
  • Crucell
  • CTT Pharmaceutical
  • Cumberland Pharmaceuticals
  • Cures Within Reach
  • CureTech
  • Curis
  • Currax Pharmaceuticals
  • CURx Pharmaceuticals
  • Cutanea Life Sciences
  • Cypress Bioscience
  • Cytodyn
  • Cytori Therapeutics
  • Daewoong Pharmaceutical
  • Daiichi Sankyo
  • Dana-Farber Cancer Institute
  • Dance Biopharm
  • DAS Therapeutics
  • Defiante Farmaceutica
  • Denali Therapeutics
  • Derma Sciences
  • Dermin
  • Dianomi Therapeutics
  • Dicerna Pharmaceuticals
  • DNA Biomedical Solutions
  • Dr. Falk Pharma
  • Dr. Reddy's Laboratories
  • Drugs for Neglected Diseases Initiative
  • DS Healthcare
  • Duke University
  • Dyax
  • Eagle Pharmaceuticals
  • Eagle Pharmaceuticals (US)
  • Easton Pharmaceuticals
  • Echo Therapeutics
  • Ecology Coatings
  • Eddingpharm
  • Egalet
  • Eisai
  • Elencee
  • Eli Lilly
  • Elite Pharmaceuticals
  • Emergent BioSolutions
  • Emory University
  • Endocyte
  • Endo Pharmaceuticals
  • Enochian Biosciences
  • Entera Bio
  • Entest BioMedical
  • EnWave
  • Epizyme
  • Epocal
  • Esperion Therapeutics
  • Eternity Healthcare
  • Eureka Genomics
  • EUSA Pharma
  • Evolva
  • Exact Sciences
  • Exelixis
  • Eyevance
  • Fairview Health System
  • FasTrack Pharmaceuticals
  • Fibrocell Science
  • Fibrogen
  • Forest Laboratories
  • Fosun Pharmaceutical
  • Fresenius Kabi Pharmaceuticals
  • FSD Pharma
  • FusionVax
  • Galapagos
  • Galmed Pharmaceuticals
  • Genentech
  • Generex Biotechnology
  • Genevant Sciences
  • Genmab
  • Gentium
  • Genzyme
  • Geron
  • Gilead Sciences
  • GlaxoSmithKline
  • Glenmark Generics Inc USA
  • Glenmark Pharmaceuticals
  • Goldfinch Bio
  • Government of Israel
  • Gravocore
  • Grifols
  • GT Biopharma
  • Hail First Pharma
  • Hainan Sihuan Pharmaceutical
  • Halo Labs
  • Halozyme Therapeutics
  • Hansen Medical
  • Health Canada
  • Health Discovery
  • Heat Biologics
  • Hefei Life Science
  • Hefei Tianhui Incubation of Technologies
  • HemoCleanse
  • Hemogenyx
  • HemPup
  • HIBM Research Group
  • Hikma Pharmaceuticals
  • Hoffmann La Roche
  • Hollister Biosciences
  • Hookipa Pharma
  • Horizon Pharma Inc
  • HyperGenomics
  • Icahn School of Medicine at Mount Sinai
  • Ice + Jam
  • IDC-GP Pharm
  • Idera Pharmaceuticals
  • Idorsia
  • iMetabolic Biopharma
  • Immugenyx
  • Immunomic
  • Immunovative Therapies
  • Impax Laboratories
  • Imprimis Pharmaceuticals
  • iNAP
  • Incuron
  • Incyte
  • Infinity Pharmaceuticals
  • Inhibitor Therapeutics
  • Innate Pharma
  • Innocoll
  • Innovation Pharmaceuticals
  • Innovus Pharmaceuticals
  • INO Therapeutics
  • Inspiration Biopharmaceuticals
  • Instrumentation Laboratory
  • IntelGenx
  • IntelliCell BioSciences
  • Intellikine
  • Internet Marketing Consortium
  • Intrexon
  • Intuitive Surgical
  • Invekra
  • Inverness Medical Innovations
  • Ionis Pharmaceuticals
  • Ipsen
  • Ironwood Pharmaceuticals
  • Israeli National Authority for Technological Innovation
  • Jaguar Health
  • Janssen Biotech
  • Janssen Pharmaceuticals
  • Jazz Pharmaceuticals
  • JFC Technologies
  • Jiangsu Alphamab
  • Jiangsu Lianhuan Pharmaceuticals
  • Jiangsu NHWA Pharmaceutical
  • John Morley Foods
  • Juniper Pharmaceuticals
  • K2M
  • Kadmon Pharmaceuticals
  • KaloBios Pharmaceuticals
  • KemPharm
  • Kensey Nash
  • Kieran Murphy
  • Kinetic Concepts
  • Kiniksa Pharmaceuticals
  • Kitov
  • Klaria
  • Knighton Foods
  • Knight Therapeutics
  • Kodiak Sciences
  • Kraig Biocraft Laboratories
  • KVK-Tech
  • Kwang Dong Pharmaceutical
  • Kyowa Hakko Kirin
  • Laboratories Acbel
  • Legend Biotech
  • Level Brands
  • LFB Biotechnologies
  • Lifestyle Delivery Systems
  • Ligand Pharmaceuticals
  • Lubrizol
  • Lumenis
  • Lundbeck
  • MabCure
  • Macrogenics
  • Magenta Therapeutics
  • MainPointe
  • Mallinckrodt Pharmaceuticals
  • Marvanal
  • Marv Enterprises
  • Massachusetts General Hospital
  • Mayne Pharma
  • McComb Foundation
  • McEwen Centre for Regenerative Medicine
  • Meda
  • Medica
  • Medica Avante
  • Medical Technologies Innovation Asia
  • Medicines Patent Pool Foundation
  • MediGene
  • MedImmune
  • Medison Pharma
  • Medivation
  • Medivir
  • Medovex
  • Melmed
  • Memory Dx
  • Merck and Co
  • Merck KGaA
  • Merck Serono
  • Merus
  • Micromet
  • Mikah Pharma
  • Millennium
  • Mimi's Rock
  • Ministry of Health
  • Labor and Welfare
  • Miraculins
  • Moderna Therapeutics
  • Moleculin Biotech
  • Mologen
  • Morgan Stanley
  • MorphoSys
  • MultiCell Immunotherapeutics
  • Munich Leukemia Laboratory
  • NantCell
  • Nantong Jinghua Pharmaceutical
  • NantWorks
  • Napo Pharmaceuticals
  • Natac Biotech
  • Natco Pharmaceuticals
  • National Green Biomed
  • Nektar Therapeutics
  • Neogenomics
  • Nephrogenex
  • Nephros
  • Neurocrine Biosciences
  • NeuroSigma
  • NeuroVive Pharmaceutical
  • NeuroVive Pharmaceutical Asia
  • NewLeaf Brands
  • Newsoara Biopharma
  • New York University
  • NexMed
  • Nextleaf Solutions
  • Nexvet
  • NGM Biopharmaceuticals
  • Nicox
  • Nordic Bioscience
  • Norgine
  • Notable Labs
  • Novadaq Technologies
  • NovaDel Pharma
  • Novan
  • Novan Therapeutics
  • Novartis
  • Novartis Vaccines and Diagnostics
  • Novocure
  • Novus Biologicals
  • Nucorion
  • Nurix
  • Nutech Medical
  • NutraOrigin
  • NXTGEN
  • Nymox Pharmaceutical
  • Oberland Capital
  • Oculus Innovative Sciences
  • Ocumension Therapeutics
  • Omeros
  • Oncologie
  • Oncolytics Biotech
  • OncoMed Pharmaceuticals
  • Onegevity
  • One Way Liver Genomics (OWL)
  • Onyx Pharmaceuticals
  • Opexa Therapeutics
  • OptiBiotix
  • OptiNose
  • Oragenics
  • Oramed Pharmaceuticals
  • Orexigen Therapeutics
  • Organovo
  • Orgenesis
  • Orion
  • Orox Pharmaceuticals
  • OrthoCyte
  • Otsuka
  • OvaMed
  • Oxford BioMedica
  • Oxis Biotech
  • Oxygen Biotherapeutics
  • OxySure Systems
  • Pan-Provincial Vaccine Enterprise
  • Parnell Pharmaceutical Holdings
  • Par Pharmaceutical
  • PDL BioPharma
  • Penwest Pharmaceuticals
  • Pernix Therapeutics
  • Perugia University
  • Pfizer
  • Pharmacyclics
  • PharmaMar
  • PharmaNova
  • Pharmastrip
  • Phosphagenics
  • Phusion Laboratoies
  • Phyto Nutricare
  • Pieris
  • Pipex Pharmaceuticals
  • Plandai Biotechnology
  • Pluristem Therapeutics
  • Portola Pharmaceuticals
  • Poseida Therapeutics
  • Pozen
  • PreMD
  • Premier Biomedical
  • Professional Compounding Centers of America
  • Progenics Pharmaceuticals
  • Prometic Life Sciences
  • ProQR Therapeutics
  • Prosidion
  • Protalix BioTherapeutics
  • Proteonomix
  • Prothena Biosciences
  • ProtoKinetix
  • Pulmatrix
  • Puma Biotechnology
  • QRxPharma
  • Quick Med Technologies
  • Quigley Corporation
  • Reata Pharmaceuticals
  • Recordati
  • Recro Pharma
  • RedHill Biopharma
  • Reedy Creek Investments
  • RegenaStem
  • Regeneron Pharmaceuticals
  • Relmada Therapeutics
  • ReNeuron
  • Resarci Therapeutics
  • Retrophin
  • rEVO Biologics
  • Revolution Medicines
  • Rigel Pharmaceuticals
  • RNL Bio
  • Roche
  • Rockefeller University
  • Roivant Sciences
  • Royalty Pharma
  • RST Biomedikal Sanayi
  • Ruthigen
  • RXi Pharmaceuticals
  • S2 Therapeutics
  • SACCO
  • Sage Therapeutics
  • Salix Pharmaceuticals
  • Sam Amer
  • Sandoz
  • Sanofi
  • Sanofi-Aventis
  • Sanofi-Pasteur
  • Santarus
  • Santen Pharmaceutical
  • SA Pathology
  • Sarepta Therapeutics
  • Seattle Genetics
  • Seelos Therapeutics
  • Senetek
  • Sermonix Pharmaceutical
  • Sheba Medical Center
  • Shenzhen BioScien Pharmaceuticals
  • Shield Therapeutics
  • Shionogi
  • Shire Pharmaceuticals
  • Shore Therapeutics
  • Sigma-Tau
  • Sinclair Pharmaceuticals
  • Sinobiopharma
  • Sinopharm
  • Skinvera
  • Skyline Diagnostics
  • Solarvest BioEnergy
  • Soliance
  • Soligenix
  • Sorrento Therapeutics
  • Spectranetics
  • Spencer Pharmaceutical
  • Spinal USA
  • St. Jude Children's Research Hospital
  • STADA Arzneimittel
  • Stealth Therapeutics
  • Stellar Biotechnologies
  • St Jude Medical
  • Strongbridge Biopharma
  • Sucampo AG
  • Sunesis Pharmaceuticals
  • SuperNova Diagnostics
  • Swedish Orphan Biovitrum
  • Symbollon
  • Synergy Strips
  • Syntopix
  • Tactical Relief
  • Taiba
  • Takeda Pharmaceutical
  • Tango Therapeutics
  • Target Group
  • Tauriga Sciences
  • TB Alliance
  • Technion Research and Development Foundation
  • Tetra Bio-Pharma
  • TetraLogic Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Texas A&M University
  • Therakine
  • Theravance
  • Theravance Biopharma
  • The Regents of the University of California
  • Thorne Research
  • Threshold Pharmaceuticals
  • TiGenix
  • Tilray
  • Titterington Veterinary Services
  • Tiziana Life Sciences
  • TONIX Pharmaceuticals
  • Torii Pharmaceutical
  • TRACON Pharmaceuticals
  • Tramorgan
  • Transgene
  • Trellis Bioscience
  • Trevena
  • Trimedyne
  • Trimeris
  • TrovaGene
  • TTFactor
  • Turnstone Biologics
  • Tyme Technologies
  • Ultragenyx Pharmaceuticals
  • Uluru
  • Unigene Laboratories
  • UniQure
  • Universal Cells
  • University Health Network
  • University of Alberta
  • University of California
  • University of Central Florida Research Foundation
  • University of Colorado
  • University of Florida Research Foundation
  • University of Geneva
  • University of Missouri
  • University of Notre of Dame
  • University of Pennsylvania
  • University of Western Sydney
  • University of Zurich
  • UOP
  • Uppsalagruppen Medical
  • Upstream Peripheral Technologies
  • UroGen Pharma
  • Valeant Pharmaceuticals
  • ValiPharma
  • Valor Biotherapeutics
  • Vanderbilt University
  • Vasomune Therapeutics
  • Vaxent
  • VBL Therapeutics (dba)
  • Veloxis Pharmaceuticals
  • Veracyte
  • Verenium
  • VeroScience
  • Vertex Pharmaceuticals
  • Vida Concepts
  • ViiV Healthcare
  • Virbac
  • Viropharma
  • VistaGen Therapeutics
  • Vividion Therapeutics
  • VolitionRX
  • Voyager Therapeutics
  • Vyera Pharmaceuticals
  • Vyrix Pharmaceuticals
  • Watson Pharmaceuticals
  • WAVE Life Sciences
  • Wisconsin Alumni Research Foundation
  • World Class Extractions
  • WPD Pharmaceuticals
  • Xbrane Bioscience
  • Xencor
  • XTL Biopharmaceuticals
  • Xynomic Pharmaceuticals
  • Yale University
  • Yeda Research and Development Company
  • Yeugnam University
  • ZAI Laboratory
  • Zalicus
  • Zenitech
  • Zenith Epigenetics
  • Ziopharm Oncology
  • ZS Pharma

For more information about this report visit https://www.researchandmarkets.com/r/4j3g2b

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.